Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis

INTRODUCTION: Rotarix™, GSK’s live attenuated rotavirus vaccine, was introduced in Japan in 2011. A recent trend in reduction of rotavirus gastroenteritis (RVGE) due to this vaccine was described. However, an observed/expected analysis showed a temporal association with intussusception within 7 days...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledent, Edouard, Lieftucht, Alfons, Buyse, Hubert, Sugiyama, Keiji, Mckenna, Michael, Holl, Katsiaryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749653/
https://www.ncbi.nlm.nih.gov/pubmed/26748506
http://dx.doi.org/10.1007/s40264-015-0376-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749653/
https://www.ncbi.nlm.nih.gov/pubmed/26748506
http://dx.doi.org/10.1007/s40264-015-0376-7

Ejemplares similares